These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3786599)

  • 1. Abnormal dexamethasone suppression test in daily chronic headache sufferers.
    Martignoni E; Facchinetti F; Manzoni GC; Petraglia F; Nappi G; Genazzani AR
    Psychiatry Res; 1986 Sep; 19(1):51-7. PubMed ID: 3786599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test in agoraphobia.
    Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
    J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol escape from suppression by dexamethasone during depression is strongly predicted by basal cortisol hypersecretion and increasing age combined.
    Maes M; Minner B; Suy E; D'Hondt P; Jacobs MP; Raus J
    Psychoneuroendocrinology; 1991; 16(4):295-310. PubMed ID: 1745698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test and coping behavior in psychosocial stress.
    Frecska E; Lukács H; Arató M; Mód L; Alföldi A; Magyar I
    Psychiatry Res; 1988 Feb; 23(2):137-45. PubMed ID: 3363022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
    Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of dexamethasone suppression to psychological test variables.
    Danahy SA; Schwartz BD; Willard SG; Winstead DK
    J La State Med Soc; 1986 Jan; 138(1):38-43. PubMed ID: 3950587
    [No Abstract]   [Full Text] [Related]  

  • 8. Dexamethasone suppression test and MMPI scales.
    Ansseau M; von Frenckell R; Franck G; Geenen V; Legros JJ
    Neuropsychobiology; 1986; 16(2-3):68-71. PubMed ID: 3587578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What does the dexamethasone suppression test identify?
    Krishnan KR; France RD; Pelton S; McCann UD; Manepalli AN; Davidson JR
    Biol Psychiatry; 1985 Sep; 20(9):957-64. PubMed ID: 4027315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsuppression of cortisol in depression and immune function.
    Syvälahti E; Eskola J; Ruuskanen O; Laine T
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):413-22. PubMed ID: 4070644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U; Naor S; Asnis G; Gasparini F; Goldstein S; Vital-Herne J; Kang BJ
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract]   [Full Text] [Related]  

  • 14. beta-Endorphin/beta-lipotropin immunoreactivity in endogenous depression. Effect of dexamethasone.
    Matthews J; Akil H; Greden J; Charney D; Weinberg V; Rosenbaum A; Watson SJ
    Arch Gen Psychiatry; 1986 Apr; 43(4):374-81. PubMed ID: 2937385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypothalamic-pituitary-adrenal system in panic disorder.
    Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
    Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
    Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
    Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative dexamethasone suppression test measurements in bulimia, depression and normal controls.
    Musisi S; Garfinkel P
    Can J Psychiatry; 1985 Apr; 30(3):190-4. PubMed ID: 3857956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary study of the dexamethasone suppression test in endogenous depression].
    Omori T; Denda K; Koyama T; Matsubara S; Yasuda M
    Seishin Shinkeigaku Zasshi; 1983; 85(11):816-9. PubMed ID: 6677917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.